- abnormal motor capabilities/coordination/movement / MGI
- ataxia / MGI
- impaired coordination / MGI
- decreased glucagon secretion / MGI
- decreased insulin secretion / MGI
- abnormal pancreatic beta cell physiology / MGI
- decreased synaptic glutamate release / MGI
- abnormal miniature excitatory postsynaptic currents / MGI
- behavior/neurological phenotype / MGI
- taste/olfaction phenotype / MGI
- decreased prepulse inhibition / MGI
C3;C-Snap25Bdr/H
Status | Available to order |
EMMA ID | EM:01844 |
Citation information | RRID:IMSR_EM:01844 Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information. |
International strain name | C3;C-Snap25Bdr/H |
Alternative name | GENA70 |
Strain type | Induced Mutant Strains : Chemically-induced |
Allele/Transgene symbol | Snap25Bdr |
Gene/Transgene symbol | Snap25 |
Information from provider
Provider | Pat Nolan |
Provider affiliation | MRC Mammalian Genetics Unit |
Genetic information | Point mutation resulting in a subtle ataxic gait from weaning age, 10-20% smaller than littermates |
Phenotypic information | Homozygous mutants die at P1, heterozygous mutants show subtle ataxic gait from weaning age, 10-20% smaller than littermates |
References |
|
Information from EMMA
Archiving centre | Mary Lyon Centre at MRC Harwell, Oxford, United Kingdom |
Disease and phenotype information
MGI allele-associated human disease models
Orphanet associated rare diseases, based on orthologous gene matching
- Presynaptic congenital myasthenic syndromes / Orphanet_98914
MGI phenotypes (allele matching)
MGI phenotypes (gene matching)
- increased white adipose tissue amount / MGI
- myoclonus / MGI
- tremors / MGI
- thin diaphragm muscle / MGI
- abnormal cerebral cortex morphology / MGI
- convulsive seizures / MGI
- abnormal skin condition / MGI
- increased body weight / MGI
- decreased body weight / MGI
- decreased body size / MGI
- delayed eyelid opening / MGI
- increased anxiety-related response / MGI
- abnormal locomotor behavior / MGI
- ataxia / MGI
- hyperactivity / MGI
- hypoactivity / MGI
- no spontaneous movement / MGI
- impaired coordination / MGI
- abnormal object recognition memory / MGI
- abnormal spatial learning / MGI
- unresponsive to tactile stimuli / MGI
- disheveled coat / MGI
- increased circulating triglyceride level / MGI
- hyperglycemia / MGI
- abnormal blood vessel morphology / MGI
- decreased embryo size / MGI
- abnormal dopamine level / MGI
- infertility / MGI
- respiratory failure / MGI
- seizures / MGI
- abnormal motor capabilities/coordination/movement / MGI
- increased circulating insulin level / MGI
- premature death / MGI
- abnormal brain morphology / MGI
- no abnormal phenotype detected / MGI
- abnormal CNS synaptic transmission / MGI
- abnormal intercostal muscle morphology / MGI
- hepatic steatosis / MGI
- akinesia / MGI
- decreased glucagon secretion / MGI
- decreased vertical activity / MGI
- increased thigmotaxis / MGI
- blotchy skin / MGI
- abnormal PNS synaptic transmission / MGI
- abnormal endplate potential / MGI
- enhanced paired-pulse facilitation / MGI
- decreased paired-pulse facilitation / MGI
- no phenotypic analysis / MGI
- decreased insulin secretion / MGI
- decreased width of hypertrophic chondrocyte zone / MGI
- abnormal pancreatic beta cell physiology / MGI
- abnormal insulin secretion / MGI
- decreased synaptic glutamate release / MGI
- abnormal miniature excitatory postsynaptic currents / MGI
- increased circulating cholesterol level / MGI
- improved glucose tolerance / MGI
- abnormal serotonin level / MGI
- insulin resistance / MGI
- behavior/neurological phenotype / MGI
- taste/olfaction phenotype / MGI
- increased susceptibility to diet-induced obesity / MGI
- increased circulating leptin level / MGI
- increased body mass index / MGI
- impaired hearing / MGI
- abnormal hippocampus CA3 region morphology / MGI
- increased white fat cell size / MGI
- decreased prepulse inhibition / MGI
- abnormal impulsive behavior control / MGI
- postnatal lethality, incomplete penetrance / MGI
- neonatal lethality, complete penetrance / MGI
- decreased circulating ghrelin level / MGI
- increased food intake / MGI
- decreased food intake / MGI
Literature references
- A systematic, genome-wide, phenotype-driven mutagenesis programme for gene function studies in the mouse.;Nolan P M, Peters J, Strivens M, Rogers D, Hagan J, Spurr N, Gray I C, Vizor L, Brooker D, Whitehill E, Washbourne R, Hough T, Greenaway S, Hewitt M, Liu X, McCormack S, Pickford K, Selley R, Wells C, Tymowska-Lalanne Z, Roby P, Glenister P, Thornton C, Thaung C, Stevenson J A, Arkell R, Mburu P, Hardisty R, Kiernan A, Erven A, Steel K P, Voegeling S, Guenet J L, Nickols C, Sadri R, Nasse M, Isaacs A, Davies K, Browne M, Fisher E M, Martin J, Rastan S, Brown S D, Hunter J, ;2000;Nature genetics;25;440-3; 10932191
- A dominant mutation in Snap25 causes impaired vesicle trafficking, sensorimotor gating, and ataxia in the blind-drunk mouse.;Jeans Alexander F, Oliver Peter L, Johnson Reuben, Capogna Marco, Vikman Jenny, Molnár Zoltán, Babbs Arran, Partridge Christopher J, Salehi Albert, Bengtsson Martin, Eliasson Lena, Rorsman Patrik, Davies Kay E, ;2007;Proceedings of the National Academy of Sciences of the United States of America;104;2431-6; 17283335
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).